Clinical Trials Logo

Epilepsy, Partial, Motor clinical trials

View clinical trials related to Epilepsy, Partial, Motor.

Filter by:
  • None
  • Page 1

NCT ID: NCT06248333 Recruiting - Clinical trials for Epilepsy, Drug Resistant

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

STEM
Start date: February 14, 2024
Phase: N/A
Study type: Interventional

The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of subthalamic nucleus (STN) as adjunctive therapy for reducing the frequency of seizures in drug-resistant focal motor epilepsy.

NCT ID: NCT03313362 Active, not recruiting - Clinical trials for Psychogenic Seizures

Detecting PNES With Single-channel sEMG

Start date: November 3, 2017
Phase: N/A
Study type: Interventional

This is a prospective, comparative, multicenter study of subjects being admitted for standard of care therapy in Epilepsy Monitoring Units in the Veteran's Affair (VA) Medical Centers.

NCT ID: NCT00744731 Completed - Clinical trials for Epilepsy, Complex Partial

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Start date: January 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to obtain long-term safety and tolerability information on carisbamate as add-on therapy for the treatment of partial onset seizures in patients with epilepsy. Seizure counts will be obtained to measure the rate of seizures for each patient during the study.

NCT ID: NCT00740623 Completed - Clinical trials for Epilepsy, Complex Partial

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Start date: January 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness, safety, and tolerability of carisbamate as add-on therapy for the treatment of partial onset seizures in patients with epilepsy.